製品名:Methyl 4-oxo-4,5-dihydroimidazo[1,2-a]quinoxaline-8-carboxylate

IUPAC Name:methyl 4-oxo-4H,5H-imidazo[1,2-a]quinoxaline-8-carboxylate

CAS番号:1452864-17-3
分子式:C12H9N3O3
純度:97%
カタログ番号:CM221314
分子量:243.22

包装単位 有効在庫 価格(USD) 数量
CM221314-1g 3-4 Weeks ƴƐȖ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1452864-17-3
分子式:C12H9N3O3
融点:-
SMILESコード:O=C(C1=CC(N2C3=NC=C2)=C(C=C1)NC3=O)OC
密度:
カタログ番号:CM221314
分子量:243.22
沸点:
MDL番号:MFCD26407248
保管方法:

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
Imidazopyrazines
In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.

Related Products